2016 annual financial data

Theravance Biopharma 2016 Financial results

Theravance Biopharma 2016 financial results with verified reported values.

Direct answer

Revenue was 48,648,000 USD.

Operating income was -180,467,000 USD and net income was -190,669,000 USD.
Operating cash flow was -98,989,000 USD.

Get free Theravance Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
48,648,000 USD
Operating income
-180,467,000 USD
Net income
-190,669,000 USD
Operating cash flow
-98,989,000 USD